Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study

Objective There is limited knowledge on the onset of comorbidities in congenital adrenal hyperplasia (CAH) during childhood. We aimed to establish the health status of children with CAH in the UK. Design and methods This cross-sectional multicentre study involved 14 tertiary endocrine UK units, recr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of endocrinology 2022-10, Vol.187 (4), p.543-553
Hauptverfasser: Bacila, Irina, Lawrence, Neil Richard, Mahdi, Sundus, Alvi, Sabah, Cheetham, Timothy D, Crowne, Elizabeth, Das, Urmi, Dattani, Mehul Tulsidas, Davies, Justin H, Gevers, Evelien, Krone, Ruth E, Kyriakou, Andreas, Patel, Leena, Randell, Tabitha, Ryan, Fiona J, Keevil, Brian, Ahmed, S Faisal, Krone, Nils P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 553
container_issue 4
container_start_page 543
container_title European journal of endocrinology
container_volume 187
creator Bacila, Irina
Lawrence, Neil Richard
Mahdi, Sundus
Alvi, Sabah
Cheetham, Timothy D
Crowne, Elizabeth
Das, Urmi
Dattani, Mehul Tulsidas
Davies, Justin H
Gevers, Evelien
Krone, Ruth E
Kyriakou, Andreas
Patel, Leena
Randell, Tabitha
Ryan, Fiona J
Keevil, Brian
Ahmed, S Faisal
Krone, Nils P
description Objective There is limited knowledge on the onset of comorbidities in congenital adrenal hyperplasia (CAH) during childhood. We aimed to establish the health status of children with CAH in the UK. Design and methods This cross-sectional multicentre study involved 14 tertiary endocrine UK units, recruiting 101 patients aged 8–18 years with classic 21-hydroxylase deficiency and 83 controls. We analysed demographic, clinical and metabolic data, as well as psychological questionnaires (Strengths and Difficulties (SDQ), Paediatric Quality of Life (PedsQL)). Results Patient height SDS in relation to mid-parental height decreased with age, indicating the discrepancy between height achieved and genetic potential height. Bone age was advanced in 40.5% patients, with a mean difference from the chronological age of 1.8 (±2.3) years. Patients were more frequently overweight (27%) or obese (22%) compared to controls (10.8% and 10.8%, respectively, P 
doi_str_mv 10.1530/EJE-21-1109
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9513639</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2706181020</sourcerecordid><originalsourceid>FETCH-LOGICAL-b400t-11141dc2b1a407a5261ff394928160e3f7029aa67c81a187ac238b16bfbfda1b3</originalsourceid><addsrcrecordid>eNp9kcFuEzEQhi0EomnhxAv4WIQMnvXGu8sBqYpSAq3EhUjcrFmvnTVy7LD2gvIGPDZOUyFx4TQj-Zv_n_FPyCvgb2Ep-Lv15zWrgAHw7glZQN10TLbi21Oy4C2vWS1rcUEuU_rOOZSePycXQpaeV3JBfm8M-jzSlDHPiUZL9ej8MJlAMQz0GOewowczpRgS_eUKqWPYmeAyeoonrtTxWIiDx-SQukDzaOj2jl6vbjZse_f6PUWqp5gSS0ZnF08T-9lnx7QJeTLFex6OL8gziz6Zl4_1imxv119XG3b_5eOn1c0962vOc7kSahh01QPWvMFlJcFa0dVd1YLkRtiGVx2ibHQLCG2DuhJtD7K3vR0QenFFPpx1D3O_N8PDCujVYXJ7nI4qolP_vgQ3ql38qbolCCm6InD9KDDFH7NJWe1d0sZ7DCbOSVUNl9CW3-UFfXNGH86fjP1rA1ydslMlO1WBOmVXaDjTvYtJu2LvrNP435k_8Facog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2706181020</pqid></control><display><type>article</type><title>Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Bacila, Irina ; Lawrence, Neil Richard ; Mahdi, Sundus ; Alvi, Sabah ; Cheetham, Timothy D ; Crowne, Elizabeth ; Das, Urmi ; Dattani, Mehul Tulsidas ; Davies, Justin H ; Gevers, Evelien ; Krone, Ruth E ; Kyriakou, Andreas ; Patel, Leena ; Randell, Tabitha ; Ryan, Fiona J ; Keevil, Brian ; Ahmed, S Faisal ; Krone, Nils P</creator><creatorcontrib>Bacila, Irina ; Lawrence, Neil Richard ; Mahdi, Sundus ; Alvi, Sabah ; Cheetham, Timothy D ; Crowne, Elizabeth ; Das, Urmi ; Dattani, Mehul Tulsidas ; Davies, Justin H ; Gevers, Evelien ; Krone, Ruth E ; Kyriakou, Andreas ; Patel, Leena ; Randell, Tabitha ; Ryan, Fiona J ; Keevil, Brian ; Ahmed, S Faisal ; Krone, Nils P</creatorcontrib><description>Objective There is limited knowledge on the onset of comorbidities in congenital adrenal hyperplasia (CAH) during childhood. We aimed to establish the health status of children with CAH in the UK. Design and methods This cross-sectional multicentre study involved 14 tertiary endocrine UK units, recruiting 101 patients aged 8–18 years with classic 21-hydroxylase deficiency and 83 controls. We analysed demographic, clinical and metabolic data, as well as psychological questionnaires (Strengths and Difficulties (SDQ), Paediatric Quality of Life (PedsQL)). Results Patient height SDS in relation to mid-parental height decreased with age, indicating the discrepancy between height achieved and genetic potential height. Bone age was advanced in 40.5% patients, with a mean difference from the chronological age of 1.8 (±2.3) years. Patients were more frequently overweight (27%) or obese (22%) compared to controls (10.8% and 10.8%, respectively, P &lt; 0.001). No consistent relationship between glucocorticoid dose and anthropometric measurements or hormonal biomarkers was detected. A small number of patients had raised total cholesterol (3.0%), low HDL (3.0%), raised LDL (7.0%) and triglycerides (5.0%). SDQ scores were within the ‘high’ and ‘very high’ categories of concern for 16.3% of patients. ‘School functioning’ was the lowest PedsQL scoring dimension with a median (interquartile range) of 70 (55–80), followed by ‘emotional functioning’ with a median of 75 (65–85). Conclusions Our results show an increased prevalence of problems with growth and weight gain in CAH children and suggest reduced quality of life. This highlights the urgent need to optimise management and monitoring strategies to improve long-term health outcomes.</description><identifier>ISSN: 0804-4643</identifier><identifier>EISSN: 1479-683X</identifier><identifier>DOI: 10.1530/EJE-21-1109</identifier><identifier>PMID: 36001026</identifier><language>eng</language><publisher>Bristol: Bioscientifica Ltd</publisher><subject>Original ; Original Research</subject><ispartof>European journal of endocrinology, 2022-10, Vol.187 (4), p.543-553</ispartof><rights>The authors</rights><rights>The authors 2022 The authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b400t-11141dc2b1a407a5261ff394928160e3f7029aa67c81a187ac238b16bfbfda1b3</citedby><cites>FETCH-LOGICAL-b400t-11141dc2b1a407a5261ff394928160e3f7029aa67c81a187ac238b16bfbfda1b3</cites><orcidid>0000-0003-0689-5549 ; 0000-0002-3402-4727</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids></links><search><creatorcontrib>Bacila, Irina</creatorcontrib><creatorcontrib>Lawrence, Neil Richard</creatorcontrib><creatorcontrib>Mahdi, Sundus</creatorcontrib><creatorcontrib>Alvi, Sabah</creatorcontrib><creatorcontrib>Cheetham, Timothy D</creatorcontrib><creatorcontrib>Crowne, Elizabeth</creatorcontrib><creatorcontrib>Das, Urmi</creatorcontrib><creatorcontrib>Dattani, Mehul Tulsidas</creatorcontrib><creatorcontrib>Davies, Justin H</creatorcontrib><creatorcontrib>Gevers, Evelien</creatorcontrib><creatorcontrib>Krone, Ruth E</creatorcontrib><creatorcontrib>Kyriakou, Andreas</creatorcontrib><creatorcontrib>Patel, Leena</creatorcontrib><creatorcontrib>Randell, Tabitha</creatorcontrib><creatorcontrib>Ryan, Fiona J</creatorcontrib><creatorcontrib>Keevil, Brian</creatorcontrib><creatorcontrib>Ahmed, S Faisal</creatorcontrib><creatorcontrib>Krone, Nils P</creatorcontrib><title>Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study</title><title>European journal of endocrinology</title><description>Objective There is limited knowledge on the onset of comorbidities in congenital adrenal hyperplasia (CAH) during childhood. We aimed to establish the health status of children with CAH in the UK. Design and methods This cross-sectional multicentre study involved 14 tertiary endocrine UK units, recruiting 101 patients aged 8–18 years with classic 21-hydroxylase deficiency and 83 controls. We analysed demographic, clinical and metabolic data, as well as psychological questionnaires (Strengths and Difficulties (SDQ), Paediatric Quality of Life (PedsQL)). Results Patient height SDS in relation to mid-parental height decreased with age, indicating the discrepancy between height achieved and genetic potential height. Bone age was advanced in 40.5% patients, with a mean difference from the chronological age of 1.8 (±2.3) years. Patients were more frequently overweight (27%) or obese (22%) compared to controls (10.8% and 10.8%, respectively, P &lt; 0.001). No consistent relationship between glucocorticoid dose and anthropometric measurements or hormonal biomarkers was detected. A small number of patients had raised total cholesterol (3.0%), low HDL (3.0%), raised LDL (7.0%) and triglycerides (5.0%). SDQ scores were within the ‘high’ and ‘very high’ categories of concern for 16.3% of patients. ‘School functioning’ was the lowest PedsQL scoring dimension with a median (interquartile range) of 70 (55–80), followed by ‘emotional functioning’ with a median of 75 (65–85). Conclusions Our results show an increased prevalence of problems with growth and weight gain in CAH children and suggest reduced quality of life. This highlights the urgent need to optimise management and monitoring strategies to improve long-term health outcomes.</description><subject>Original</subject><subject>Original Research</subject><issn>0804-4643</issn><issn>1479-683X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kcFuEzEQhi0EomnhxAv4WIQMnvXGu8sBqYpSAq3EhUjcrFmvnTVy7LD2gvIGPDZOUyFx4TQj-Zv_n_FPyCvgb2Ep-Lv15zWrgAHw7glZQN10TLbi21Oy4C2vWS1rcUEuU_rOOZSePycXQpaeV3JBfm8M-jzSlDHPiUZL9ej8MJlAMQz0GOewowczpRgS_eUKqWPYmeAyeoonrtTxWIiDx-SQukDzaOj2jl6vbjZse_f6PUWqp5gSS0ZnF08T-9lnx7QJeTLFex6OL8gziz6Zl4_1imxv119XG3b_5eOn1c0962vOc7kSahh01QPWvMFlJcFa0dVd1YLkRtiGVx2ibHQLCG2DuhJtD7K3vR0QenFFPpx1D3O_N8PDCujVYXJ7nI4qolP_vgQ3ql38qbolCCm6InD9KDDFH7NJWe1d0sZ7DCbOSVUNl9CW3-UFfXNGH86fjP1rA1ydslMlO1WBOmVXaDjTvYtJu2LvrNP435k_8Facog</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Bacila, Irina</creator><creator>Lawrence, Neil Richard</creator><creator>Mahdi, Sundus</creator><creator>Alvi, Sabah</creator><creator>Cheetham, Timothy D</creator><creator>Crowne, Elizabeth</creator><creator>Das, Urmi</creator><creator>Dattani, Mehul Tulsidas</creator><creator>Davies, Justin H</creator><creator>Gevers, Evelien</creator><creator>Krone, Ruth E</creator><creator>Kyriakou, Andreas</creator><creator>Patel, Leena</creator><creator>Randell, Tabitha</creator><creator>Ryan, Fiona J</creator><creator>Keevil, Brian</creator><creator>Ahmed, S Faisal</creator><creator>Krone, Nils P</creator><general>Bioscientifica Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0689-5549</orcidid><orcidid>https://orcid.org/0000-0002-3402-4727</orcidid></search><sort><creationdate>20221001</creationdate><title>Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study</title><author>Bacila, Irina ; Lawrence, Neil Richard ; Mahdi, Sundus ; Alvi, Sabah ; Cheetham, Timothy D ; Crowne, Elizabeth ; Das, Urmi ; Dattani, Mehul Tulsidas ; Davies, Justin H ; Gevers, Evelien ; Krone, Ruth E ; Kyriakou, Andreas ; Patel, Leena ; Randell, Tabitha ; Ryan, Fiona J ; Keevil, Brian ; Ahmed, S Faisal ; Krone, Nils P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b400t-11141dc2b1a407a5261ff394928160e3f7029aa67c81a187ac238b16bfbfda1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Original</topic><topic>Original Research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bacila, Irina</creatorcontrib><creatorcontrib>Lawrence, Neil Richard</creatorcontrib><creatorcontrib>Mahdi, Sundus</creatorcontrib><creatorcontrib>Alvi, Sabah</creatorcontrib><creatorcontrib>Cheetham, Timothy D</creatorcontrib><creatorcontrib>Crowne, Elizabeth</creatorcontrib><creatorcontrib>Das, Urmi</creatorcontrib><creatorcontrib>Dattani, Mehul Tulsidas</creatorcontrib><creatorcontrib>Davies, Justin H</creatorcontrib><creatorcontrib>Gevers, Evelien</creatorcontrib><creatorcontrib>Krone, Ruth E</creatorcontrib><creatorcontrib>Kyriakou, Andreas</creatorcontrib><creatorcontrib>Patel, Leena</creatorcontrib><creatorcontrib>Randell, Tabitha</creatorcontrib><creatorcontrib>Ryan, Fiona J</creatorcontrib><creatorcontrib>Keevil, Brian</creatorcontrib><creatorcontrib>Ahmed, S Faisal</creatorcontrib><creatorcontrib>Krone, Nils P</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bacila, Irina</au><au>Lawrence, Neil Richard</au><au>Mahdi, Sundus</au><au>Alvi, Sabah</au><au>Cheetham, Timothy D</au><au>Crowne, Elizabeth</au><au>Das, Urmi</au><au>Dattani, Mehul Tulsidas</au><au>Davies, Justin H</au><au>Gevers, Evelien</au><au>Krone, Ruth E</au><au>Kyriakou, Andreas</au><au>Patel, Leena</au><au>Randell, Tabitha</au><au>Ryan, Fiona J</au><au>Keevil, Brian</au><au>Ahmed, S Faisal</au><au>Krone, Nils P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study</atitle><jtitle>European journal of endocrinology</jtitle><date>2022-10-01</date><risdate>2022</risdate><volume>187</volume><issue>4</issue><spage>543</spage><epage>553</epage><pages>543-553</pages><issn>0804-4643</issn><eissn>1479-683X</eissn><abstract>Objective There is limited knowledge on the onset of comorbidities in congenital adrenal hyperplasia (CAH) during childhood. We aimed to establish the health status of children with CAH in the UK. Design and methods This cross-sectional multicentre study involved 14 tertiary endocrine UK units, recruiting 101 patients aged 8–18 years with classic 21-hydroxylase deficiency and 83 controls. We analysed demographic, clinical and metabolic data, as well as psychological questionnaires (Strengths and Difficulties (SDQ), Paediatric Quality of Life (PedsQL)). Results Patient height SDS in relation to mid-parental height decreased with age, indicating the discrepancy between height achieved and genetic potential height. Bone age was advanced in 40.5% patients, with a mean difference from the chronological age of 1.8 (±2.3) years. Patients were more frequently overweight (27%) or obese (22%) compared to controls (10.8% and 10.8%, respectively, P &lt; 0.001). No consistent relationship between glucocorticoid dose and anthropometric measurements or hormonal biomarkers was detected. A small number of patients had raised total cholesterol (3.0%), low HDL (3.0%), raised LDL (7.0%) and triglycerides (5.0%). SDQ scores were within the ‘high’ and ‘very high’ categories of concern for 16.3% of patients. ‘School functioning’ was the lowest PedsQL scoring dimension with a median (interquartile range) of 70 (55–80), followed by ‘emotional functioning’ with a median of 75 (65–85). Conclusions Our results show an increased prevalence of problems with growth and weight gain in CAH children and suggest reduced quality of life. This highlights the urgent need to optimise management and monitoring strategies to improve long-term health outcomes.</abstract><cop>Bristol</cop><pub>Bioscientifica Ltd</pub><pmid>36001026</pmid><doi>10.1530/EJE-21-1109</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-0689-5549</orcidid><orcidid>https://orcid.org/0000-0002-3402-4727</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0804-4643
ispartof European journal of endocrinology, 2022-10, Vol.187 (4), p.543-553
issn 0804-4643
1479-683X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9513639
source Oxford University Press Journals All Titles (1996-Current)
subjects Original
Original Research
title Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T15%3A30%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Health%20status%20of%20children%20and%20young%20persons%20with%20congenital%20adrenal%20hyperplasia%20in%20the%20UK%20(CAH-UK):%20a%20cross-sectional%20multi-centre%20study&rft.jtitle=European%20journal%20of%20endocrinology&rft.au=Bacila,%20Irina&rft.date=2022-10-01&rft.volume=187&rft.issue=4&rft.spage=543&rft.epage=553&rft.pages=543-553&rft.issn=0804-4643&rft.eissn=1479-683X&rft_id=info:doi/10.1530/EJE-21-1109&rft_dat=%3Cproquest_pubme%3E2706181020%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2706181020&rft_id=info:pmid/36001026&rfr_iscdi=true